Related Experiment Videos
Spinal anaesthesia with gamma hydroxybutyrate. A study in a rat model
M Chanimov1, M Bahar, M L Cohen
1Department of Anaesthesiology, Assaf Harofeh Medical Centre, Zerifin, Israel.
European Journal of Anaesthesiology
|July 3, 1999
Summary
Gamma hydroxybutyrate shows promise as a spinal anesthetic. Administered intrathecally in rats, it provided anesthesia and muscle relaxation without significant side effects.
Area of Science:
- Neuroscience
- Anesthesiology
- Pharmacology
Background:
- Gamma hydroxybutyrate (GHB) is an endogenous neurotransmitter and metabolite of gamma-aminobutyric acid (GABA).
- GHB and its sodium salt have demonstrated sedative and anesthetic properties.
- Previous research indicates GHB's utility in managing alcohol withdrawal syndrome.
Purpose of the Study:
- To evaluate the anesthetic potential of intrathecal gamma hydroxybutyrate (GHB) in an animal model.
- To compare the efficacy of GHB, alone and in combination with fentanyl, against intrathecal lignocaine for intraoperative anesthesia.
Main Methods:
- Seventy-two Wistar rats were used, divided into six groups with intrathecal catheters.
- Rats received intrathecal boluses of GHB (alone or with fentanyl) or lignocaine.
- Anesthetic effects, including antinociception and muscle relaxation, were assessed.
Main Results:
- Intrathecal GHB induced reversible segmental antinociception and muscle relaxation in rats.
- Moderate sedation was observed without significant hemodynamic or respiratory depression.
- GHB demonstrated comparable anesthetic effects to intrathecal lignocaine.
Conclusions:
- Gamma hydroxybutyrate shows potential as a spinal anesthetic agent.
- Intrathecal administration of GHB offers a promising alternative for anesthesia.
- Further research is warranted to explore GHB's clinical applications in spinal anesthesia.